| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alternative splicing in aging and aging-related diseases: From pathogenesis to therapy
|
Han, Mingrui
|
|
|
272 |
C |
p.
|
article
|
| 2 |
Characteristics and pharmacological responsiveness in hiPSC models of inherited cardiomyopathy
|
Gerritse, Merel
|
|
|
272 |
C |
p.
|
article
|
| 3 |
Corrigendum to “Immunomodulation and targeted drug delivery with high intensity focused ultrasound (HIFU): Principles and mechanisms” [Volume 244, April 2023, 108393]
|
Ashar, Harshini
|
|
|
272 |
C |
p.
|
article
|
| 4 |
Editorial Board
|
|
|
|
272 |
C |
p.
|
article
|
| 5 |
Editorial: Pharmacological targets for the control of tissue remodelling and fibrosis
|
Holzer, Peter
|
|
|
272 |
C |
p.
|
article
|
| 6 |
Neuromuscular and cardiac organoids and assembloids: Advanced platforms for drug testing
|
Fontanelli, Lorenzo
|
|
|
272 |
C |
p.
|
article
|
| 7 |
Post-COVID pulmonary sequelae: Mechanisms and potential targets to reduce persistent fibrosis
|
Vreeman, Emma C.A.
|
|
|
272 |
C |
p.
|
article
|
| 8 |
The free fatty acid receptor 2 (FFA2): Mechanisms of action, biased signaling, and clinical prospects
|
Li, Yang
|
|
|
272 |
C |
p.
|
article
|
| 9 |
The many facets of biased signaling: Mechanisms and possible therapeutic implications
|
Solís, K. Helivier
|
|
|
272 |
C |
p.
|
article
|
| 10 |
Unlocking the power of affibody conjugated radioactive metallopharmaceuticals for targeted cancer diagnosis and therapy
|
Murugan, Dhanashree
|
|
|
272 |
C |
p.
|
article
|
Journal description